New Fox Chase Attending Physician Focuses on Genitourinary Cancers
PHILADELPHIA (September, 2008) —Betsy Plimack, MD, has joined Fox Chase Cancer Center’s medical oncology staff as an attending physician. She treats patients with genitourinary cancers such as bladder, kidney, prostate and testicular cancers.
Plimack received her MD at New York University and served her internship and residency at NYU Medical Center and Bellevue Hospital.
She also held a fellowship in medical oncology at The University of Texas M. D. Anderson Cancer Center, serving as chief resident. She also earned a master's degree in patient-based biologic research at University of Texas Graduate School of Biomedical Science.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.